House Energy and Commerce Health Subcommittee members, including several health care professionals, recently made clear their concerns about the US sunscreen market offering consumers fewer choices than other countries.
Discussion during a 1 April hearing on reauthorizing the Food and Drug Administration’s OTC monograph user fee program (OMUFA) of introducing additional OTC sunscreen ingredients...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?